Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
The second Monday of February is International
#EpilepsyDay where people come together to highlight problems faced by the 65 million people living with#epilepsy worldwide. Yet despite the high prevalence, many patients will not receive treatmentpic.twitter.com/KTmFjkNbN9 -
UCB scientists have discovered the first ‘small molecules’ that could inhibit TNF – a key protein involved in inflammatory diseases, including rheumatoid arthritis https://www.ucb.com/our-science/magazine/detail/article/Inflammatory-diseases-Big-news-on-small-molecules …pic.twitter.com/KPwbVJE30m
-
Check out the new Data Transparency Policy section on our website https://www.ucb.com/our-company/magazine/detail/article/Research-transparency-adds-value-for-patients …
#RWE#RWD#BigData#transparencypic.twitter.com/GBqx1OO3xr
-
UCB is proud to announce an important treatment milestone in Japan. Learn more https://www.ucb.com/stories-media/Press-Releases/article/CIMZIA-certolizumab-pegol-now-Available-for-Patients-in-Japan-living-with-Multiple-Psoriatic-Diseases …pic.twitter.com/DSQAD27A1d
-
The drug development process can take 10-15 years from early-stage discovery to marketing authorization.
#AI has the potential to accelerate this process and make it significantly more efficient. Find out more https://www.ucb.com/our-science/magazine/detail/article/Can-AI-reinvent-drug-design …pic.twitter.com/Bt4XHvcqTM
-
#DYK that women who experience a first fragility fracture are at significant risk for experiencing subsequent fractures, particularly in the 2 years after the fracture? Read a summary of the findings published in the Journal of Bone and Mineral Research https://www.healio.com/endocrinology/bone-mineral-metabolism/news/online/%7Be82f5153-e1e2-41d0-bcee-211865734e7b%7D/recent-fracture-addressable-risk-factor-for-new-fracture …pic.twitter.com/dApxlEbDGa
-
Based on a recent UCB survey, almost 1 in 5 patients living with
#osteoporosis reported having to reduce their working hours, and one in 8 said the condition meant they had to give up work completely. https://www.ucb.com/patients/magazine/detail/article/Osteoporosis-patients-believe-their-condition-is-neglected …pic.twitter.com/sCYjE5yE5O
-
Is
#osteoporosis a neglected condition? We asked patients https://www.ucb.com/patients/magazine/detail/article/Osteoporosis-patients-believe-their-condition-is-neglected …pic.twitter.com/oULVYLxtGq
-
We’re counting down to 2020 - not just a new day or a new year but a new decade! Stay tuned for news on the 2020’s promising innovations
#InspiredByPatients#DrivenBySciencepic.twitter.com/JNnjvbLbHf -
It’s a special time of the year all over the world. We want to show our appreciation to everyone who has helped us delivering new solutions to patients
#InspiredByPatients#DrivenBySciencepic.twitter.com/THUXlNpGHA -
UCB is playing its part in tackling the ‘silent epidemic’ of
#osteoporosis https://www.ucb.com/our-company/magazine/detail/article/Osteoporosis-speaking-up-against-a-%E2%80%98silent-epidemic%E2%80%99 …pic.twitter.com/VKE8C6OVRb
-
There are approximately 5 million people living with rheumatoid arthritis in China, women are especially impacted. We are proud to support these patients by providing new treatment options. Learn more http://bit.ly/2ZdfUeO
#RApic.twitter.com/bLuOFODUbx
-
We're supporting students interested in a career in
#STEM. Find out what happened when 37 students visited our#labs.#InspiredByPatients#DrivenByScience https://www.ucb.com/our-science/magazine/detail/article/Life-in-the-lab-Students-sample-life-as-a-UCB-scientist …pic.twitter.com/hiBOstsGgp
-
We're exploring how
#wearables could help monitor treatment outcomes for patients with#Parkinsons@CPathInstitute https://www.ucb.com/patients/magazine/detail/article/Can-wearable-sensors-add-value-for-Parkinson%E2%80%99s-patients …pic.twitter.com/huCYsTaTq3
-
Discover what it's really like being a
#scientist working on#MedicinesDevelopment.#InspiredByPatients#DrivenByScience https://www.ucb.com/our-science/magazine/detail/article/Life-in-the-lab-Students-sample-life-as-a-UCB-scientist …pic.twitter.com/6R6d83Nm1t
-
#Parkinsons is forecast to affect 12.9 million people by 2040. Read how#wearables could accelerate the development of new therapeutic options for people living with PD https://www.ucb.com/patients/magazine/detail/article/Can-wearable-sensors-add-value-for-Parkinson%E2%80%99s-patients …pic.twitter.com/uo62nHIR9X
-
We've announced final results from our Phase II study for the treatment of patients with primary
#ITP at#ASH19 https://www.ucb.com/stories-media/Press-Releases/article/UCB-Presents-Final-Results-from-Phase-II-Study-of-Rozanolixizumab-in-Primary-Immune-Thrombocytopenia-ITP-at-2019-ASH-Annual-Meeting …pic.twitter.com/qtHj98AMSf
-
At this year’s
#RSNA19, we’re proud to announce our new#bonebot which helps diagnose and grade vertebral#fragilityfractures using#AI. Find out more here: http://bit.ly/2sSoUtB#RSNA19pic.twitter.com/fh0oI0OUxy
-
One vertebral fracture occurs every 22 seconds worldwide in men and women over age 50! Our novel
#bonebot aims to detect these#fragilityfractures which have a detrimental impact on daily living. Learn more here: http://bit.ly/2sSoUtB#RSNA19pic.twitter.com/7gsVxnF2Lk
-
For some people,
#ITP can be an ‘invisible disease’ with symptoms that can't always be seen and can come and go. Look out for these symptoms.#ASH19 http://bit.ly/UCBatASH pic.twitter.com/R6jYK2lVRL
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.